Pharmaids Pharmaceuticals Balance Sheet Annual

Trade

BSE: 524572 | NSE: - | ISIN: INE117D01018 | Sector: Major Drugs

70.00 -2.60 (-3.58%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash	4.80	12.75	0.41	0.00
Short Term Investments	0.00	3.31	-	-
Cashand Short Term Investments	4.80	16.06	0.41	0.20
Accounts Receivable- Trade Net	2.68	1.39	1.34	0.28
Total Receivables Net	2.68	1.39	1.34	0.28
Total Inventory	3.59	0.00	0.89	0.37
Other Current Assets Total	2.46	0.07	0.03	0.01
Total Current Assets	13.53	17.51	2.67	0.86
Property/ Plant/ Equipment Total- Net	38.46	2.11	0.48	0.49
Goodwill Net	31.42	-	-	-
Intangibles Net	0.55	-	-	-
Long Term Investments	0.58	-	-	-
Other Long Term Assets Total	6.81	2.83	0.36	0.35
Total Assets	91.34	24.59	11.11	9.12
Accounts Payable	5.12	1.88	2.31	0.50
Notes Payable/ Short Term Debt	1.77	0.00	0.00	0.00
Current Portof LT Debt/ Capital Leases	0.71	0.00	0.00	-
Other Currentliabilities Total	3.98	0.24	0.13	0.09
Total Current Liabilities	11.58	2.13	2.44	0.59
Long Term Debt	3.59	0.00	0.00	0.00
Capital Lease Obligations	2.47	-	-	-
Total Long Term Debt	6.05	0.00	0.00	0.00
Total Debt	8.53	0.00	0.00	0.00
Minority Interest	-1.55	-	-	-
Other Liabilities Total	3.22	0.00	0.00	0.00
Total Liabilities	19.29	2.13	2.44	0.59
Common Stock Total	35.27	21.44	10.27	10.27
Retained Earnings( Accumulated Deficit)	36.78	0.67	-1.60	-1.74
Other Equity Total	0.00	0.35	-	-
Total Equity	72.05	22.46	8.67	8.53
Total Liabilities Shareholders' Equity	91.34	24.59	11.11	9.12
Total Common Shares Outstanding	3.53	2.15	1.03	1.03
Tangible Book Valueper Share Common Eq	11.37	10.45	8.41	8.27
Note Receivable- Long Term	-	2.14	7.61	7.42
Deferred Income Tax	-	0.00	0.00	0.00
Cash Equivalents	-	-	-	0.20